Jazz Pharmaceuticals, Inc. (JAZZ)
$7.03
-0.21 (-2.90%)
| CAPS Rating |
|
|---|---|
| Open | $7.10 |
| Previous Close | $7.24 |
| Daily Range | $6.97 - $7.24 |
| 52-Week Range | $0.51 - $11.88 |
| Market Cap | $217.87M |
| P/E Ratio | 1.12 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 178,132 |
| Average Daily Volume | 688,000 |
JAZZ
VS S&P 500 (SPY)
How do you think JAZZ will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
JAZZ Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
JAZZ News and Commentary
- 5 Stocks That Laugh at Wall Street – The Motley Fool
- What are some pharmaceutical stocks that will be reviewed by the FDA soon? – Blog at The Motley Fool
- Why We Love Wild Penny Stocks ... in a Recession – The Motley Fool
- Correct me if I am wrong, but I think I have found a gem – Blog at The Motley Fool
- Wall Street's Buy List – The Motley Fool
- Time to get risky: Buying the Pharm – Blog at The Motley Fool
- 10 Stocks to Shake the Market – The Motley Fool
- 9 Stocks to Shake the Market – The Motley Fool
- Biotechs on fire after WHO declares Swine Flu a Pandemic – Blog at The Motley Fool
- Not a coincedence that Drug stocks are Soaring ahead of Phase I, II, and III data – Blog at The Motley Fool
- 5 Deathbed Stocks – The Motley Fool
Related News and Articles
- This Baby Is a Nice Addition – The Motley Fool
- Now Is the Time to Buy Risk – The Motley Fool
- 4-Star Stocks Poised to Pop: Merck – The Motley Fool
- Pfizer Dodges a Bullet – The Motley Fool
- Pfizer's Generic Growth, With a Side of Sashimi – The Motley Fool
- Why You Can't Afford to Miss These Stocks – The Motley Fool
- The Government Won't Be There for You – The Motley Fool
RSS Headlines
Fool UK
